US Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices votes unanimously to recommend Shingrix for immunocompromised adults aged 19 and up

/PRNewswire/ -- GlaxoSmithKline plc today announced that the US Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices...

Related Keywords

Australia ,Japan ,United States ,New Zealand ,Hong Kong ,United Kingdom ,Philadelphia ,Pennsylvania ,Middlesex ,United Kingdom General ,Singapore ,Brazil ,China ,Brentford ,Hounslow ,Canada ,London ,City Of ,Americans ,Simon Moore ,Evan Berland ,Jeff Mclaughlin ,Sonya Ghobrial ,Sean Clements ,Prnewswire Glaxosmithkline ,Mick Readey ,James Dodwell ,Sabine Luik ,Nick Stone ,Centers For Disease ,Human Services ,Us Centers For Disease ,European Commission ,Drug Administration ,Advisory Committee On Immunization Practices ,Company Annual Report On Form ,Us Department Of Health ,Disease Control ,Advisory Committee ,Immunization Practices ,Zoster Vaccine Recombinant ,Chief Medical Officer ,Medical Regulatory ,Varicella Zoster Virus ,Mortality Weekly Report ,Safety Information ,Annual Report ,Infect Dis ,Adjuvanted Herpes Zoster Subunit Vaccine ,Gsk ,